Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BDPP for Stress-Related Disorders
NCT04421079Phase 1Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jan 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of bioactive dietary polyphenol preparation in Stress-related disorders and major depressive disorder (MDD) (4 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: Dihydrocaffeic Acid Level. Started Jan 2021; status: completed.
02
Drugs
bioactive dietary polyphenol preparation
03
Conditions
Stress-related disordersmajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04421079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04421079.